Do analysts prefer CRON or ACB?

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor CRON or ACB?

In the previous week, Cronos Group and Cronos Group both had 5 articles in the media. Aurora Cannabis' average media sentiment score of 0.75 beat Cronos Group's score of 0.63 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CGC or CRON?

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media prefer CGC or CRON?

In the previous week, Canopy Growth had 4 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Canopy Growth and 5 mentions for Cronos Group. Canopy Growth's average media sentiment score of 1.01 beat Cronos Group's score of 0.63 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 4 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts recommend CRON or OGI?

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's higher probable upside, research analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor CRON or OGI?

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Cronos Group and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Cronos Group's score of 0.63 indicating that Organigram Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, CRON or SNDL?

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $146.59M 6.92 -$9.45M $0.01 271.00 SNDL $677.32M 0.54 -$11.29M -$0.03 N/A

Is CRON or SNDL more profitable?

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity. Company Net Margins Return on Equity Return on Assets Cronos Group -1.14% -1.26% -1.20% SNDL -1.19% -1.02% -0.85%

Does the media favor CRON or SNDL?

In the previous week, SNDL had 1 more articles in the media than Cronos Group. MarketBeat recorded 6 mentions for SNDL and 5 mentions for Cronos Group. SNDL's average media sentiment score of 1.06 beat Cronos Group's score of 0.63 indicating that SNDL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CRON or TLRY?

In the previous week, Tilray Brands had 8 more articles in the media than Cronos Group. MarketBeat recorded 13 mentions for Tilray Brands and 5 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.63 beat Tilray Brands' score of 0.29 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Tilray Brands 3 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Cronos Group (CRON) Competitors

$2.71 -0.02 (-0.73%)

Closing price 04:00 PM Eastern

Extended Trading

$2.70 0.00 (-0.18%)

As of 07:11 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? MarketBeat compares Cronos Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Cronos Group compare to Aurora Cannabis?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Cronos Group has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Aurora Cannabis	-23.46%	-0.04%	-0.03%

In the previous week, Cronos Group and Cronos Group both had 5 articles in the media. Aurora Cannabis' average media sentiment score of 0.75 beat Cronos Group's score of 0.63 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aurora Cannabis has higher revenue and earnings than Cronos Group. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00
Aurora Cannabis	$246.72M	0.85	$1.63M	-$1.08	N/A

Summary

Cronos Group beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Canopy Growth has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$225.65M	1.84	-$429.86M	-$1.30	N/A
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -94.39%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-94.39%	-46.85%	-28.95%
Cronos Group	-1.14%	-1.26%	-1.20%

In the previous week, Canopy Growth had 4 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Canopy Growth and 5 mentions for Cronos Group. Canopy Growth's average media sentiment score of 1.01 beat Cronos Group's score of 0.63 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	4 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Cronos Group beats Canopy Growth on 12 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Cronos Group has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Cronos Group and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Cronos Group's score of 0.63 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's higher probable upside, research analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Organigram Global	-9.22%	-13.41%	-9.09%

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Cronos Group beats Organigram Global on 10 of the 15 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

Cronos Group (NASDAQ:CRON) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

In the previous week, SNDL had 1 more articles in the media than Cronos Group. MarketBeat recorded 6 mentions for SNDL and 5 mentions for Cronos Group. SNDL's average media sentiment score of 1.06 beat Cronos Group's score of 0.63 indicating that SNDL is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
SNDL	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 15.13%. SNDL has a consensus target price of $5.00, indicating a potential upside of 254.61%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A

8.7% of Cronos Group shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
SNDL	-1.19%	-1.02%	-0.85%

Cronos Group has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, SNDL has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market.

Summary

Cronos Group beats SNDL on 9 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Cronos Group (NASDAQ:CRON) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Tilray Brands	-156.51%	-3.31%	-2.42%

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 15.13%. Tilray Brands has a consensus price target of $11.50, indicating a potential upside of 125.05%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

In the previous week, Tilray Brands had 8 more articles in the media than Cronos Group. MarketBeat recorded 13 mentions for Tilray Brands and 5 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.63 beat Tilray Brands' score of 0.29 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Tilray Brands	3 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Comparatively, 0.8% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00
Tilray Brands	$821.31M	0.73	-$2.19B	-$13.65	N/A

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.02B	$2.93B	$6.47B	$12.54B
Dividend Yield	N/A	1.68%	2.69%	5.22%
P/E Ratio	271.27	12.23	18.89	22.53
Price / Sales	6.92	302.27	520.79	112.26
Price / Cash	217.76	55.72	41.34	57.13
Price / Book	0.90	3.85	9.84	6.72
Net Income	-$9.45M	$75.85M	$3.57B	$337.19M
7 Day Performance	-0.37%	-1.67%	-1.16%	0.48%
1 Month Performance	2.65%	22.18%	3.85%	5.07%
1 Year Performance	40.41%	21.83%	27.40%	34.25%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.5809 of 5 stars	$2.71 -0.7%	$2.30 -15.1%	+42.2%	$1.02B	$146.59M	271.27	450
ACB Aurora Cannabis	0.7947 of 5 stars	$3.64 +1.1%	N/A	-32.6%	$212.78M	$373.12M	N/A	1,130	News Coverage
CGC Canopy Growth	2.1801 of 5 stars	$1.08 -0.9%	N/A	-12.4%	$440.49M	$225.65M	N/A	3,150	News Coverage Positive News Analyst Upgrade
OGI Organigram Global	0.7715 of 5 stars	$1.13 -0.9%	N/A	-16.8%	$160.48M	$185.07M	N/A	1,139	Gap Up
SNDL SNDL	3.4552 of 5 stars	$1.46 -1.4%	$5.00 +242.5%	+13.4%	$380.95M	$677.32M	N/A	2,751	News Coverage Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Which has more volatility and risk, CRON or ACB?

Is CRON or ACB more profitable?

Does the media favor CRON or ACB?

Do institutionals and insiders have more ownership in CRON or ACB?

Do analysts prefer CRON or ACB?

Which has preferable earnings & valuation, CRON or ACB?

Summary

How does Cronos Group compare to Canopy Growth?

Which has more risk and volatility, CGC or CRON?

Do analysts rate CGC or CRON?

Do institutionals & insiders have more ownership in CGC or CRON?

Which has preferable valuation and earnings, CGC or CRON?

Is CGC or CRON more profitable?

Does the media prefer CGC or CRON?

Summary

How does Cronos Group compare to Organigram Global?

Which has more risk & volatility, CRON or OGI?

Does the media favor CRON or OGI?

Which has stronger earnings & valuation, CRON or OGI?

Do analysts recommend CRON or OGI?

Is CRON or OGI more profitable?

Do institutionals and insiders have more ownership in CRON or OGI?

Summary

How does Cronos Group compare to SNDL?

Does the media favor CRON or SNDL?

Do analysts recommend CRON or SNDL?

Which has better earnings and valuation, CRON or SNDL?

Do insiders and institutionals have more ownership in CRON or SNDL?

Is CRON or SNDL more profitable?

Which has more volatility & risk, CRON or SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Is CRON or TLRY more profitable?

Do analysts recommend CRON or TLRY?

Which has more volatility and risk, CRON or TLRY?

Does the media favor CRON or TLRY?

Do insiders & institutionals have more ownership in CRON or TLRY?

Which has higher valuation and earnings, CRON or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools